Skip to main content
TipRanks
Go Ultimate75% OFF

Phreesia (19P) Q2 2027 Earnings Report

3 Followers

DE:19P Q2 2027 EPS Results

Actual EPS
EUR 0.03
Consensus EPS
EUR 0.08
Beat/Miss
Missed by -EUR 0.05
One Year Ago EPS
EUR 0.01

DE:19P Q2 2027 Revenue Results

Actual Revenue
EUR 117.44M
Expected Revenue
EUR 117.08M
Beat/Miss
Beat by +EUR 358.32K
YoY Revenue Growth
+10.41%

Earnings Announcement Details

Quarter
Q2 2027
Date
09/02/2026
Time
After Close
Conference Call
Wednesday, September 2, 2026
DE:19P Upcoming Earnings

Phreesia's next earnings date is estimated for December 2, 2026, based on past reporting schedules.

Q2 2027 Earnings Call Audio

DE:19P Q2 2027 Earnings Call
0:00 / 0:00

Q2 2027 Earnings Slide Deck

Q2 2027 Earnings Call Summary

Q2 2027
Earnings Call Date:Sep 02, 2026|% Change Since:10.78%|
Earnings Call Sentiment|Positive

The call was strongly constructive, with 10% year-over-year revenue growth, substantial adjusted EBITDA expansion, positive net income for the fifth consecutive quarter, continued positive cash flow, more than $23 million of debt reduction, and reaffirmed fiscal 2027 guidance. AccessOne, Provider Connect, the GLP-1 campaign, and AI initiatives showed encouraging momentum. The main challenges were sequential declines tied to payment-processing seasonality, provider economic strain, pricing moderation, and some earlier volume weakness beyond seasonality.

Company Guidance

For fiscal 2027, Phreesia is maintaining its revenue outlook at a range of $510 million to $520 million, including approximately $37 million of contribution from AccessOne and no additional revenue from potential future acquisitions completed between now and January 31, 2027; adjusted EBITDA guidance remains at a range of $125 million to $135 million, with the restructuring plan expected to result in meaningful annualized run rate expense savings, and AHSC growth expected in the mid-single-digit percentage range and total revenue per AHSC growth in the low single-digit percentage range.

  • Revenue Growth in Line with ExpectationsSecond-quarter revenue was $129.5 million, up 10% year-over-year, with revenue growth and profitability expansion described as in line with expectations.
  • Client Base Continued to ExpandAverage health care services clients reached 4,744, increasing by 36 sequentially and 277 year-over-year. Client additions were in line with expectations and consistent with the full-year outlook for AHSC growth in the mid-single-digit percentage range.
  • Revenue per Client Increased Year-over-YearTotal revenue per AHSC was $27,289, up 4% year-over-year.
  • Strong Adjusted EBITDA and Margin ExpansionAdjusted EBITDA was $32.9 million, an increase of $10.8 million year-over-year, with an adjusted EBITDA margin of 25%.
  • Fifth Consecutive Quarter of Positive Net IncomeNet income was $1.9 million compared with $700,000 in the prior-year period, marking the company's fifth consecutive quarter of positive net income.
  • Positive Cash Flow and Debt ReductionThe company delivered its ninth consecutive quarter of positive operating cash flow and free cash flow. Operating cash flow was $18.3 million, up $3.5 million year-over-year, and free cash flow was $13.8 million, up $4.2 million year-over-year. Together with available cash, this enabled more than $23 million of debt principal reduction while maintaining a healthy cash balance.
  • AccessOne Early Market TractionManagement said it feels better about the AccessOne acquisition than when it closed, citing extensive internal and external conversations, early wins in the market, very positive client feedback, and expectations that AccessOne will be a growth lever over the next couple of years.
  • AccessOne Included in Fiscal 2027 OutlookThe fiscal 2027 revenue outlook assumes approximately $37 million of contribution from AccessOne.
  • Provider Connect MomentumProvider Connect, the newest Network Solutions offering, was described as continuing to build momentum and resonating with customers. Management said business activity and progress in Network Solutions had improved relative to 90 and 180 days earlier.
  • GLP-1 Campaign Produced Positive ResultsA four-month GLP-1 study generated a 4% incremental lift in new-to-brand prescriptions versus a matched control group and more than 1,000 new patient starts. Management also said the pilot helped convert some new business activity.
  • Fiscal 2027 Outlook ReaffirmedThe company maintained its fiscal 2027 revenue outlook at $510 million to $520 million and its adjusted EBITDA outlook at $125 million to $135 million. It also maintained expectations for AHSC growth in the mid-single-digit percentage range and total revenue per AHSC growth in the low single-digit percentage range.
  • Expected Restructuring SavingsThe restructuring plan implemented in May is expected to result in meaningful annualized run-rate expense savings, which were reflected in the outlook provided on March 30 and reaffirmed on May 27.
  • Continued Product and Revenue-Cycle InvestmentManagement said products including Plan Match, eligibility and verification capabilities, payment estimation, and coordination of benefits have been well received. The company is continuing its commitment to tools that help providers manage their practices, revenue cycle, and operational needs.
  • Broad AI Deployment and Product OpportunityManagement said AI is being embraced across the organization and is affecting operations, product development, sales, and client support. Examples cited included voice AI and Plan Match, with AI enabling faster and more cost-effective testing and development. The company is continuing to invest in AI across Network Solutions, payments, and workflow.
  • Expanding Provider-Side FootprintManagement said the company is adding more footprint on the provider side, supporting business momentum and helping the team generate wins across the business.
  • Stable Payment Volume Commentary in the QuarterThe company said there was nothing notable to call out in the second quarter regarding volume trends or deductible-reset trends across the approximately 180 million visits it facilitates.

DE:19P Earnings History

DE:19P earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Dec 02, 20262027 (Q3)0.11-0.06――
Sep 02, 20262027 (Q2)0.080.030.01200.00% (+0.02)
May 27, 20262027 (Q1)0.010.05-0.06171.43% (+0.11)
Mar 30, 20262026 (Q4)0.060.02-0.1118.18% (+0.12)
Dec 08, 20252026 (Q3)0.000.06-0.23128.00% (+0.29)
Sep 04, 20252026 (Q2)-0.060.01-0.28103.23% (+0.29)
May 28, 20252026 (Q1)-0.11-0.06-0.3280.00% (+0.25)
Mar 12, 20252025 (Q4)-0.16-0.10-0.5180.36% (+0.41)
Dec 09, 20242025 (Q3)-0.21-0.23-0.5356.90% (+0.30)
Sep 04, 20242025 (Q2)-0.32-0.28-0.6254.41% (+0.34)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed